159 results about "Treated patient" patented technology

Introduced here are pressure-mitigation systems able to mitigate the pressure applied to a human body by the surface of an object (also referred to as a "structure") and assist a caretaker to move the human body. A controller device (or simply "controller") can be fluidically coupled to a pressure-mitigation device that includes a series of selectively inflatable chambers. When a pressure-mitigation device is placed between a human body and a surface, the controller can continuously, intelligently, and autonomously circulate fluid through the chambers of the pressure-mitigation device. Normally, the controller circulates air through the chambers of the pressure-mitigation device, though the controller could circulate another fluid, such as water or gel, through the chambers of the pressure-mitigation device. The controller may cause the chambers to be selectively inflated, deflated, or any combination thereof. As chambers selectively inflate, certain portions of the human body may be lifted above the surface, turned, or any combination thereof.

The present invention is in the field of ocular disease therapy. In particular, the invention relates to a composition comprising pimecrolimus for use in the topical treatment of moderate to severe blepharitis, in particular in a patient group comprising subjects with a clinical diagnosis of moderate to severe blepharitis, wherein the subjects to be treated have signs and symptoms of moderate to severe blepharitis characterised by swelling of the eyelid margin, ocular debris and ocular discomfort. In particular, the present invention relates to an ophthalmic composition that shows a high patient acceptance and a clinically meaningful improvement in the signs and symptoms of treated patients.

The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition with the effects of treating atrial fibrillation and improving anxiety, a medicine and a preparation method and application thereof. When the traditional Chinese medicine composition provided by the invention is combined with auricular point pressing beans to treat patients with atrial fibrillation and anxiety, clinical symptoms of atrial fibrillation and anxiety can be further improved, specifically, the score of traditional Chinese medicine syndromes is reduced, the effective rate of electrocardiograms and the clinical effective rate of anxiety are improved, the life quality of the patients is improved, and no obvious adverse reaction exists. Meanwhile, a traditional Chinese medicine oral administration and traditional Chinese medicine external treatment combined method is adopted, syndrome differentiation treatment can be carried out from the holism concept, the holographic therapy of external treatment of internal diseases can be utilized to the maximum extent, and a simple, convenient, safe and effective treatment thought is provided for early prevention, early diagnosis and early treatment of more diseases.

Provided herein are methods for determining a subtype of a small cell lung cancer in a patient based on the express status of ASCL1, NEUROD1, and POU2F3, which are expressed in a mutually exclusive fashion. The subtype of the cancer can be used to determine the sensitivity of the cancer to certain anti-cancer therapies. As such, also provided are methods of treating patients having small cell lung cancer based on the subtyping results.

1. Name of the designed product: Non-invasive respirator (HepoRes R2). 2. Use of the designed product: Medical equipment for treating patients with respiratory insufficiency requiring mechanical ventilation. 3. Design points of the designed product: in shape. 4. Picture or photo best indicating the design points: perspective view 1.

To provide a method of treating a patient with chronic heart failure using a medicament comprising neuregulin.SOLUTION: A companion diagnostic test is first performed on each patient prior to treatment, and the appropriate treatment is provided to each patient according to the companion diagnostic test results. If the test results are within a preferred therapeutic range for treatment, the patient is suitable for treatment of heart failure by administration of an effective amount of neuregulin.SELECTED DRAWING: None

The present invention provides tissue processing systems, apparatus, and methods. [Solution] Provided herein is a system for treating patient tissue. The system comprises an energy delivery console and at least one energy delivery device. The energy delivery console can deliver a first dose of energy and a second dose of energy. The energy delivery device comprises a first delivery element configured to deliver a first dose of energy to target tissue and a second delivery element configured to deliver a second dose of energy to target tissue. The first dose of energy may include the delivery of energy that reversibly alters the target tissue, and the second dose of energy may include the delivery of energy that irreversibly alters the target tissue. The first dose of energy is delivered to enhance the therapy provided by the second dose of energy.

The invention is a method for treating patients with Parkinson's disease by orally administering a controlled release levodopa formulation and the method provides an improvement of a patient's total post-dose “Off” time, total post dose “On” time and total post dose “Good On” time compared to post-dose of treatment regimens with oral immediate release levodopa tablets.

The invention relates to neurodegenerative disorders, and the diagnosis and / or prognosis of neurodegenerative disorders in a test subject using a lateral flow test, or the like. The invention also relates to detecting diagnostic and prognostic biomarkers in a range of various patient sample types for diagnosing and / or prognosing neurodegenerative disorders, such as Alzheimer's disease. The invention further provides biomarker detection methods, and apparatus and apparatuses for diagnosing and prognosing neurodegenerative disorders, and methods of treating patients diagnosed or prognosed with a neurodegenerative disorder. The invention also extends to detection of biomarkers and / or screening in pre-symptomatic subjects, for early diagnosis, to enable disease prevention or intervention.

An auricular stimulation device having surface electrodes biased towards each other, and offset from one another, is provided. The stimulation device can be positioned about the ear of a patient with each of the electrodes overlaying auricular ear tissue containing innervation supplied by an auricular branch of the vagus nerve. The electrodes transcutaneously stimulate the auricular branch. Also provided is a method of treating a patient using the auricular stimulation device. The stimulation device can be used for treating patients with conditions such as high blood pressure, depression, high blood glucose level, and tinnitus. Also provided is a diagnostic and therapeutic system having the auricular stimulation device, a smart device and a monitoring device. The smart device controls the auricular stimulation device based on biomarker information received from the monitoring device; and on information related to the patient, such as age, musculoskeletal stability, etc.; and / or on user input.

The invention provides stable ophthalmic formulations, a unit dose containing such formulations, medical kits, and methods for making and using such formulations and unit doses to treat patients suffering from a disorder mediated by an αv integrin, such as diabetic retinopathy.

Systems, devices, user interfaces, and methods for managing patient conditions. A system for monitoring and / or managing a patient suffering from a brain condition may include a controller obtaining and / or storing data related to one or more monitored patient parameters contributing to the brain condition of the patient and displaying values of the one or more monitored patient parameters in trend lines over time on a user interface. The displayed trend lines may represent values of ventricular CSF volume, values of IVH volume, total ventricular volume in the brain, and / or values of other suitable parameters. The data related to the one or more monitored patient parameters may include images of the patient's brain and / or data derived from images of the patient's brain and / or suitable patient data.

The invention relates to a multifunctional nursing bed and a control method thereof.The multifunctional nursing bed comprises a bed head, a bed tail, an upper bed frame, a lower bed frame, a rotation driving device and a bottom bed frame, the bed frame is horizontally arranged at the top of the lower bed frame, the upper bed frame is rotationally arranged at the top of the lower bed frame with a vertical line as a rotating shaft, and the rotation driving device is arranged on the lower bed frame and drives the upper bed frame to rotate horizontally; the upper bed frame comprises a backrest frame, a waist frame, a leg lifting frame, a backrest overturning driving device and a leg lifting driving device, and the leg lifting driving device drives the leg lifting frame to overturn up and down. The rotary driving device is used for driving the upper bed frame to rotate horizontally, and the backrest overturning driving device is used for driving the backrest frame to overturn up and down, so that a patient can conveniently get in and out of the bed or change the rest posture of the patient. Besides, the leg lifting frame can lift the legs under the driving of the leg lifting driving device, so that a doctor or a nurse can treat the patient conveniently. Therefore, the upper bed frame can be changed into a backrest chair and can be flattened to realize the functions of sitting, sleeping and lifting legs.

The present disclosure relates to articles having an active pharmaceutical ingredient integrated into a thermoplastic polymer, as well as to methods of use and preparation of such articles. The articles are used, for example, for medical devices and for treating patients.

The present invention relates to methods for treating patients with cancer, including patients with hematological malignancy, wherein the method comprises administering to the patient a therapeutically effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein R1 and R2 are as defined herein.

A system and method for determining patient hospitalization risk and treating patients is disclosed. The system and method may include extracting patient data from one or more databases corresponding to a pool of patients having end stage renal disease; using a predictive model with the extracted patient data to generate, for each of the patients, a respective expected probability for hospitalization within a predetermined time period; identifying a subset of patients having respective expected probabilities that are higher than other patients in the pool of patients; identifying, for each patient, at least one factor from the patient data that increased the expected probability of hospitalization; and based on the identified factors, determining and executing clinical interventions to lower the probability of hospitalization within the subset of the pool of patients.

Provided herein are targeting constructs for sustained transgene expression of inducible cell death systems that include degron mutants and cereblon mutants. Also provided are pharmaceutical compositions comprising the targeting constructs, and methods for use of the same. The methods of use include methods of inducing cell death in a cell, and methods of treating patients in need thereof.

A patient support apparatus for use in treating patients with behavioral health indicia, including a base supporting wheels for movement along a floor surface, a litter for supporting a patient, and a lift mechanism to move the litter relative to the base between a lowered position and a raised position. A skirt barrier having a bottom edge defining a periphery is operatively attached to the litter for concurrent movement with the litter between an exposed configuration and a shield configuration. The exposed configuration corresponds to the raised position and is defined with the bottom edge spaced vertically above the base. The shield configuration corresponds to the lowered position and is defined with the bottom edge arranged adjacent to the floor surface and with the periphery extending around the base to at least partially limit external access to the base.

Novel methods are disclosed for treating patients with Parkinson's disease and other primary and secondary parkinsonian disorders by improving cell engraftment. Treating patients with antihyperlipidemic drugs and / or CSF-1R antagonists before, during, and / or after transplantation of DA neurons improves cell viability, engraftment, proliferation, migration, or differentiation of the administered DA neurons. Methods are disclosed for pre-treating patients to improve engraftment of administered cells. Methods are disclosed for pre-treating patients to improve engraftment of administered progenitor cells.

This application generally relates to an transcatheter anti-reflux venous valve endoprosthesis system, including a replacement valve, a valve support frame, crimping system, and delivery system to treat patients with chronic venous insufficiency, and method for using such a system.

The utility model belongs to the technical field of phototherapy instruments, and particularly relates to a clamping device with a positioning structure, which comprises a phototherapy instrument body. The side wall of the phototherapy instrument body is fixedly connected with a supporting arm. A plurality of positioning rods are connected into the supporting arm in a sliding manner; the top of the positioning rod is fixedly connected with an adjusting plate; the bottom of the supporting arm is fixedly connected with a driving motor; the affected part of the patient is supported through the positioning rod and the pushing plate, and the limb of the affected part of the patient can be fixed, so that the structural design that the limb of the affected part of the patient is close to or far away from the phototherapy lamp is achieved, and the functions of fixing the limb of the affected part of the patient and limiting sliding of the pushing plate at the same time are achieved; the problems that when the phototherapy instrument is used for treating a patient, the placement position of the affected part of the patient is prone to being inaccurate, the illumination of the illumination instrument deflects, when the illumination deflects, the treatment effect of the phototherapy instrument is prone to being affected, and the treatment effect of the phototherapy instrument is poor are effectively solved.

Provided herein are methods for determining a subtype of a small cell lung cancer in a patient based on the express status of ASCL1, NEUROD1, and POU2F3, which are expressed in a mutually exclusive fashion. The subtype of the cancer can be used to determine the sensitivity of the cancer to certain anti-cancer therapies. As such, also provided are methods of treating patients having small cell lung cancer based on the subtyping results.

This application generally relates to an transcatheter anti-reflux venous valve endoprosthesis system, including a replacement valve, a valve support frame, crimping system, and delivery system to treat patients with chronic venous insufficiency, and method for using such a system.

The utility model discloses a dual-wavelength laser therapeutic machine, and particularly relates to the technical field of medical instruments, the dual-wavelength laser therapeutic machine comprises a dual-wavelength laser therapeutic machine body, the upper part of the rear end of the outer surface of the dual-wavelength laser therapeutic machine body is fixedly connected with a clamping mechanism, and the rear side of the outside of the clamping mechanism is slidably connected with a bearing mechanism. A transmission mechanism is fixedly connected to the right side of the upper portion of the optical fiber tube, a transmission mechanism is fixedly connected to the upper portion of the transmission mechanism, and a clamping mechanism is fixedly connected to the middle of the transmission mechanism. According to the dual-wavelength laser therapeutic machine, the clamping mechanism can clamp and limit the bearing mechanism, the transmission mechanism can transmit laser beams conveniently, a patient can be treated conveniently under the action of the transmission mechanism, and the dual-wavelength laser therapeutic machine is simple in structure and convenient to use. And the transmission mechanism can be conveniently clamped and fixed through the clamping mechanism, so that the practicability and universality of the device are improved.

The present invention relates to methods for treating patients with cancer, including patients with hematological malignancy, wherein the method comprises administering to the patient a therapeutically effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein R1 and R2 are as defined herein.

The present disclosure provides methods and materials related to MANPs. In one embodiment, the present disclosure provides a method for treating hypertension with metabolic syndrome by administering MANPs to a patient in need of such treatment. In one embodiment, the present disclosure provides a method comprising administering MANPs to a patient to lower blood pressure (BP). In one embodiment, the method of the present disclosure is employed to treat patients with low baseline cGMP levels. In one embodiment, the present disclosure provides a therapeutic method using MANPs to increase or improve plasma cGMP levels, plasma ANP-like peptide levels, insulin sensitivity, or plasma NEFA levels. In one embodiment, the present disclosure provides a therapeutic method using MANPs to lower plasma glucose levels.

Systems and methods for probing a patient's problem using an ultrasound surgical aspirator that includes a tip for treating tissue of a patient and a console coupled to a handpiece. The console provides an AC drive signal to the ultrasound handpiece that vibrates the tip against the patient tissue. The AC drive signal includes a first component having a resonant frequency of the ultrasonic handpiece and a second component having a probing frequency less than the resonant frequency. The console measures a voltage and a current of the AC drive signal, calculates a resistance associated with the ultrasound handpiece based on the measured voltage and current, and then provides at least one of an audible, visual, or tactile indication based on the calculated resistance.

The application provides chimeric antigen receptors (CARs) that target cluster of differentiation 19 (CD 19) and / or cluster of differentiation 22 (CD22), and their uses in tumor immunotherapy. The application also provides polynucleotides and vectors that encode the CARs, as well as host cells comprising the CARs. The application also provides methods for preparing host cells comprising the CARs and methods for treating patients using the modified host cells.

The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for preventing or treating progressive hearing loss of large vestibular aqueduct syndrome as well as a preparation method and application of the traditional Chinese medicine composition. The traditional Chinese medicine composition is prepared from fructus psoraleae, herba cistanche, rhizoma drynariae, poria peel, polyporus umbellatus, cortex mori radicis, plantain herb, radix salviae miltiorrhizae, ligusticum wallichii, caulis spatholobi and honey-fried licorice root. The traditional Chinese medicine composition disclosed by the invention has the effects of tonifying kidney and strengthening primordial qi, and tonifying spleen and promoting urination, and is mainly used for preventing or treating patients with progressive hearing loss caused by large vestibular aqueduct syndrome. Compared with western medicine glucocorticoid, the traditional Chinese medicine composition has no adverse reaction, the health risk is reduced, and the treatment tolerance and compliance of patients are improved. A standardized scheme for preventing or treating progressive hearing loss of large vestibular aqueduct syndrome by traditional Chinese medicine is formed, clinical popularization is facilitated, more patients are benefited, a reference basis is provided for subsequent research, and related medical research is promoted.

This utility model discloses a medical split-type underwear, comprising a medical underwear with an opening through which a split-type block is movably connected. A loop is fixedly connected to the medical underwear. A bell-shaped buckle shell is movably connected to the side of the medical underwear. The loop has symmetrical first tightening openings and second tightening openings on its side. An elastic cord is movably connected inside the loop. A locking shaft is movably connected inside the bell-shaped buckle shell. A Z-shaped plastic elastic block is movably connected inside the bell-shaped buckle shell. Symmetrical first Velcro fasteners are fixedly connected inside the medical underwear. Symmetrical second Velcro fasteners are fixedly connected to the split-type block. This structure allows for quick splitting, facilitating medical personnel in examining and treating patients, meeting different nursing needs, improving flexibility and hygiene, and ensuring wearing comfort.